Gilead Calls $50M Cancer Drug Bonus Demand 'Absurdity'
A Gilead Sciences Inc. attorney dismissed as "absurdity" on Tuesday claims that the company's $375 million purchase of Calistoga Pharmaceuticals Inc. in 2011 mandated a conditional $50 million bonus payment if a...To view the full article, register now.
Already a subscriber? Click here to view full article